Virax Biolabs Group Ltd financial data

Symbol
VRAX on Nasdaq
Location
Lanarkshire, United Kingdom
Fiscal year end
31 March
Latest financial report
20-F - Q1 2025 - 02 Jul 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4,341,956 shares 69%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets $6,426,903 USD 17%
Liabilities $964,750 USD 179%